- Home
- ZEPP vs BRNS Comparison
ZEPP vs BRNS Comparison
Compare ZEPP & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEPP
- BRNS
- Stock Information
- Founded
- ZEPP 2013
- BRNS 2016
- Country
- ZEPP China
- BRNS United Kingdom
- Employees
- ZEPP N/A
- BRNS N/A
- Industry
- ZEPP Computer Manufacturing
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- ZEPP Technology
- BRNS Health Care
- Exchange
- ZEPP Nasdaq
- BRNS Nasdaq
- Market Cap
- ZEPP 48.8M
- BRNS 41.0M
- IPO Year
- ZEPP N/A
- BRNS 2021
- Fundamental
- Price
- ZEPP $2.80
- BRNS $1.11
- Analyst Decision
- ZEPP
- BRNS Strong Buy
- Analyst Count
- ZEPP 0
- BRNS 2
- Target Price
- ZEPP N/A
- BRNS $4.00
- AVG Volume (30 Days)
- ZEPP 11.1K
- BRNS 63.4K
- Earning Date
- ZEPP 11-18-2024
- BRNS 11-06-2024
- Dividend Yield
- ZEPP N/A
- BRNS N/A
- EPS Growth
- ZEPP N/A
- BRNS N/A
- EPS
- ZEPP N/A
- BRNS N/A
- Revenue
- ZEPP $208,946,095.00
- BRNS $14,969,000.00
- Revenue This Year
- ZEPP N/A
- BRNS $1,805.74
- Revenue Next Year
- ZEPP $18.83
- BRNS N/A
- P/E Ratio
- ZEPP N/A
- BRNS N/A
- Revenue Growth
- ZEPP N/A
- BRNS 106.21
- 52 Week Low
- ZEPP $2.06
- BRNS $0.80
- 52 Week High
- ZEPP $8.40
- BRNS $4.16
- Technical
- Relative Strength Index (RSI)
- ZEPP 45.22
- BRNS 54.91
- Support Level
- ZEPP $2.78
- BRNS $0.98
- Resistance Level
- ZEPP $2.94
- BRNS $1.25
- Average True Range (ATR)
- ZEPP 0.18
- BRNS 0.14
- MACD
- ZEPP 0.00
- BRNS 0.03
- Stochastic Oscillator
- ZEPP 17.57
- BRNS 68.82
About ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in two segments: Xiaomi Wearable Products and Self-branded products & others. The product portfolio includes smartwatches and fitness bands. The majority is from Self-branded products & other segments. It generates majority of the revenue from Xiaomi Wearable Products segment.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.